Gntbm's Self-Developed Anti-Cancer New Drug Gntbm-38 Has Obtained Ind Approval From The U.S. FDA For Phase I Clinical Trials

GNT Biotech & Medicals Corp TPEX:7427:

• GNTBM'S SELF-DEVELOPED ANTI-CANCER NEW DRUG GNTBM-38 HAS OBTAINED IND APPROVAL FROM THE U.S. FDA FOR PHASE I CLINICAL TRIALS

• GNT BIOTECH & MEDICALS CORP - GNTBM TO ADVANCE GNTBM-38 INTO MULTI-NATIONAL CLINICAL TRIALS IN U.S., CHINA, TAIWAN